On February 25, Zomedica Corp. (ZOM) provided its Q4 and fiscal 2021 revenue and gross margin update. Consequently, the stock rebounded in the after-hours on
Zomedica Corp. (ZOM) is veterinary wellness and health-based company. It offers diagnostics and treatments for pets by fixing their unmet medical needs. The company’s product
The shares of Zomedica Corp. (ZOM) have increased 4.51% to $0.7420 in premarket trading as of last check. Zomedica stock ended Thursday’s session down -3.43%
FuelCell Energy Inc. (FCEL) stock soared 4.75% to $10.15 in the pre-market trading. The most recent rating by JP Morgan, on November 19, 2020, is
DPW Holdings Inc. (DPW) stock soared 2.5% to $7.37 in the pre-market trading after the company revealed that its power electronics business, Coolisys Technologies Corp.,
The global generics drug market continues to grow with the increasing demand for more medication. Drug manufacturers are continuously striving to meet the need for
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.